Tessera Therapeutics is an early-stage life sciences company focused on pioneering Gene Writing technology, which allows for the permanent modification of the human genome. This innovative approach enables scientists and clinicians to introduce therapeutic messages into the genome, offering a potential cure for diseases at their source. By building on recent advancements in gene therapy and gene editing, Tessera Therapeutics aims to address significant limitations in these areas, enhancing their applicability and effectiveness. Founded by Flagship Pioneering, the company is positioned to transform genetic medicine and improve patient care through its groundbreaking technology.
Epirus, Inc. specializes in the design and development of advanced artificial intelligence-based defense systems aimed at countering drones and asymmetric technologies. Founded in 2018 and located in Hawthorne, California, the company produces high-powered microwave products, including its flagship technology, ELECTROMAGNETIC PULSE, which serves as a drone countermeasure. This innovative solution employs multiple simultaneous beams to neutralize unmanned aircraft systems, while also utilizing software-defined electromagnetic pulse technology to enhance its effectiveness. By integrating computer vision and machine learning, Epirus aims to optimize the detection and tracking of various threats, providing defense organizations with the capability to stun drones or disrupt swarms effectively. The company's products address critical national security challenges in both defense and commercial sectors.
DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Our revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
Redwood Materials, Inc. is a recycling and materials processing company based in Carson City, Nevada, founded in 2017. The company specializes in developing sustainable methods for recycling various metals and materials, particularly from batteries and electronics, to support circular supply chains. Its focus includes lithium, nickel, copper, gold, silver, cobalt, and other critical elements used in electric vehicles, renewable energy storage, and consumer electronics. By providing environmentally sound recycling solutions, Redwood Materials aims to address the increasing demand for battery end-of-life management as the number of electric vehicles rises globally. The company's innovative technology not only recycles waste but also generates essential raw materials, enabling manufacturers to create sustainable products and significantly contributing to the transition towards a circular economy.
Element Biosciences, Inc. develops genetic analysis tools for the research and diagnostic markets. The company provides a disruptive DNA sequencing technology and a sequencing platform, such as surface chemistry, sequencing chemistry, detection, and data analysis. The company was incorporated in 2017 and is based in San Diego, California.
Jetti Resources is a Canadian company founded in 2014, headquartered in Vancouver, specializing in the development of hydrometallurgical technology for metal extraction from mineral ores. The company focuses on extracting copper from low-grade primary sulfides, particularly chalcopyrite, the most abundant copper mineral ore. Jetti's proprietary catalytic technology effectively addresses the challenges associated with recovering vast amounts of trapped resources, significantly enhancing copper yields while being cost-effective and environmentally responsible. In addition to copper, the technology can also be applied to the extraction of zinc and nickel from sulfide ores, contributing to more efficient mineral processing practices.
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company offers a comprehensive food analytics platform that utilizes next-generation sequencing to analyze the molecular contents of foods and ingredients. This platform provides food manufacturers, suppliers, and retailers with crucial transparency across supply chains, testing products for authenticity, contaminants, allergens, and various other factors such as GMOs, heavy metals, and nutrition. Clear Labs also focuses on simplifying complex diagnostics for clinical and applied markets, combining DNA sequencing, robotics, and cloud-based analytics to improve accuracy and accelerate outcomes. By delivering insights into food safety and quality, Clear Labs aims to enhance understanding and management of potential health risks associated with food products and emerging pathogens.
Gyroscope is an ophthalmology company developing gene therapies for the treatment of eye diseases linked to an unbalanced complement system. Gyroscope was founded to explore the convergence of advancements made in the understanding of the complement system’s impact on eye disease, the genetic basis of Age-related Macular Degeneration (AMD) and gene therapy as a mode of treatment delivery.
Insitro is a operator of a data-driven drug discovery and development company that uses machine learning and high-throughput biology to transform the way that drugs are discovered and delivered to patients. The company uses state-of-the-art technologies from Bioengineering enabling it to generate high-throughput, functional genomic data sets and aligning them with patient data via a novel machine learning methods, thereby building predictive models that can accelerate target selection and the design and development of effective therapeutics.
Tenaya Therapeutics, Inc. develops therapeutics for heart failure. It offers cellular regeneration platform, that enables in vivo reprogramming of cardiac fibroblasts into cardio myocytes by delivering proprietary transcription factors; gene therapy platform, that enables the targeted delivery of a payload to cardiac fibroblasts ; and precision medicine platform, which provides personalized medicine approach to treat heart disease. The company was founded in 2016 and is headquartered in South San Francisco, California.
Vividion Therapeutics, Inc., a biotechnology company, develops therapeutics to treat major unmet medical needs using the platform for proteome-wide small molecule drug discovery. The company combines a proteome-wide small molecule screening approach and synthetic chemistry techniques. It provides small molecule selectivity and creates a path to drugging any protein. The company was incorporated in 2013 and is based in San Diego, California.
Rad Power Bikes LLC manufactures and sells electric bikes. It offers accessories, such as bags and storage, fenders and comfort products, racks and transport products, and safety and security products. The company also provides replacement parts, including batteries, brake pads, chargers, seats and grips, tires, and tubes. It sells its products online. Rad Power Bikes LLC was incorporated in 2015 and is based in Seattle, Washington.
Affinivax, Inc. is a biotechnology company based in Lexington, Massachusetts, that specializes in developing vaccines using its innovative Multiple Antigen Presenting System (MAPS) technology. This approach allows for the combination of protective polysaccharides and proteins in a single vaccine, aiming to enhance the immune response against various infectious diseases. Affinivax focuses on a range of pathogens, including Streptococcus pneumoniae, which poses significant health risks to both children and adults. The company seeks to create vaccines that provide broader disease coverage and address infectious diseases lacking effective immunization strategies. Founded in 2014, Affinivax benefits from insights provided by leading experts in infectious diseases and vaccines, and it has secured support from the Bill & Melinda Gates Foundation, along with exclusive licensing rights from Boston Children’s Hospital for its MAPS technology.
FogPharma is a healthcare company founded in 2015 and headquartered in Gloucester, Massachusetts. The firm is dedicated to the pharmaceutical sector, with a primary focus on developing innovative treatments for cancer. It operates with the support of a diverse group of private and institutional investors, fostering collaboration among its founders, employees, and advisors. FogPharma aims to create a new class of medicines designed to extend and enhance the lives of cancer patients. The company's commitment to its mission drives its efforts to pioneer effective solutions in cancer treatment.
FLEXE, Inc. operates a cloud-based warehousing services marketplace that connects organizations needing additional storage and fulfillment capacity with those that have surplus space. Founded in 2013 and based in Seattle, Washington, the company provides a platform that facilitates efficient warehouse sourcing and setup, streamlining material handling operations for clients including retailers, wholesalers, manufacturers, and logistics firms. By addressing inventory overflow and fulfillment challenges, FLEXE enhances the logistics industry and enables businesses to achieve greater structural flexibility in their operations. The company aims to optimize the global delivery of goods and improve access to affordable warehousing solutions, ultimately helping enterprises strengthen their distribution networks and maximize revenue potential.
Imago BioSciences, based in San Carlos, California, is a biotechnology company focused on developing innovative therapies for hematologic diseases, including bone marrow failure, leukemia, myelodysplastic syndrome, and acute myelogenous leukemia. Founded in 2012, the company specializes in medicines that target genetic and epigenetic mechanisms to alter gene expression patterns, aiming to create transformative treatments for conditions that present significant challenges to patients and healthcare providers. By leveraging a skilled team and robust financial backing, Imago BioSciences is dedicated to addressing a select group of orphan diseases, striving to improve patient outcomes and enhance the quality of life for those affected.
Nuro, Inc. is a technology company based in Mountain View, California, that specializes in the manufacture of self-driving vehicles designed for local goods transportation. Incorporated in 2016, Nuro focuses on transforming local commerce through autonomous delivery services. The company operates a fleet of electric, fully autonomous vehicles capable of delivering a wide range of products, from food to pharmaceuticals. Nuro's mission is to enhance everyday life by providing quick, affordable, and safe delivery solutions for merchants and their customers.
Freenome, Inc., is an artificial intelligence (AI) genomics biotech company. The company develops and provides a medical arti?cial intelligence platform for early detection of cancer. It develops blood tests for early-cancer screening and treatment selection. The company also provides clinical research services. Freenome, Inc. was founded in 2014 and is based in South San Francisco, California.
Alignment Healthcare is dedicated to transforming the complex and confusing process of medical treatment so that every link in the healthcare continuum becomes more efficient, productive and effective. The company partners with providers, health plans and hospitals to create a seamless, fast and easy-to-navigate healthcare experience, which results in happier, healthier and more satisfied patients. Based in Irvine, California, Alignment Healthcare provides partners with an end-to-end continuous care program, including clinical care coordination, risk management capabilities, and IT enablement
Generation Bio is a genetic medicines company based in Cambridge, Massachusetts, that specializes in developing gene therapies aimed at treating both rare and prevalent diseases. Established in 2016, the company focuses on conditions affecting the liver, retina, skeletal muscle, central nervous system, and oncology. Generation Bio employs an innovative non-viral platform that includes a proprietary high-capacity DNA construct known as closed-ended DNA (ceDNA), a cell-targeted lipid nanoparticle delivery system (ctLNP), and a scalable, capsid-free manufacturing process. This approach allows for the targeted delivery of genetic materials, including large and multiple genes across various tissues, and enables redosable treatments tailored to individual patient needs. By enhancing access to therapies for rare diseases and addressing more common conditions, Generation Bio aims to provide durable and sustainable treatment options for patients throughout their lives.
Allbirds, Inc. is a San Francisco-based company founded in 2015 that specializes in manufacturing eco-friendly footwear and apparel. The company offers a range of products, including wool runners, tree runners, tree loungers, tree skippers, and insoles for men, women, and children. Allbirds is committed to sustainability, utilizing premium natural materials to create comfortable and well-designed shoes that align with its mission of reducing environmental impact. The brand distinguishes itself by emphasizing thoughtfulness over flash in the footwear industry. Products are sold through a combination of physical stores and online platforms, with a significant portion of revenue generated from sales within the United States.
Convoy, Inc. operates an online marketplace that provides digital freight network services, facilitating the transportation of goods across the United States. Founded in 2015 and based in Seattle, Washington, the company allows users to book local and regional trucks on demand, accommodating loads ranging from a single pallet to full truckloads. Convoy's platform includes features such as instant quotations, online booking, automated loading suggestions, and real-time shipment tracking, enhancing operational efficiency for shippers. The company aims to address inefficiencies in the trucking industry, which faces significant carbon waste from empty trucks, by leveraging technology and data. Convoy collaborates with major clients, including Fortune 500 companies, to lower logistics costs and meet sustainability goals while improving earnings for drivers.
Gusto is a company that provides a comprehensive web-based payroll and human resource management solution tailored for small and medium-sized businesses in the United States. Its online platform facilitates payroll processing, benefits management, and human resource services, offering features such as health insurance, workers’ compensation, 401(k) contributions, time tracking, and integration services. Gusto enables employers and employees to manage payroll and benefits conveniently through web-enabled devices. The platform also allows employees and contractors to access their pay stubs, payroll forms, and personal information. Founded in 2011 by Edward Kim, Joshua Reeves, and Tomer London in San Francisco, Gusto serves a diverse range of clients, including startups, healthcare providers, creative agencies, and retail businesses, with an additional office located in Denver, Colorado.
Framebridge, Inc. specializes in custom framing solutions for art and photographs, offering a streamlined online service that prioritizes customer experience. Founded in 2014 and based in Washington, D.C., the company allows users to select from a curated range of contemporary frame styles, upload images, or send physical items for personalized framing. The expert team at Framebridge handcrafts frames to meet each customer's specifications, ensuring high-quality results. Finished products are shipped directly to consumers, typically arriving within days and ready to hang. Pricing is transparent and based on the size of the framed item, starting at $39 and including free shipping. Framebridge operates manufacturing facilities in Richmond, Kentucky, and Lanham, Maryland, and has attracted investments from notable firms and individuals in the retail and technology sectors.
Checkr, Inc. is a technology company specializing in the background check industry. Founded in 2014 and headquartered in San Francisco, California, Checkr provides a range of screening services, including criminal record checks, driving checks, social security number traces, drug tests, and credit checks. The company offers solutions for compliance and security, featuring bank-level security, continuous monitoring, and a high availability infrastructure. Checkr also provides continuous check solutions and Checkr Connect IDV, which integrates identity verification with background checks. Serving diverse sectors such as financial services, healthcare, retail, and staffing, Checkr aims to streamline the background check process through its advanced technology, offering faster turnaround times compared to traditional providers. By enhancing transparency and fairness in hiring, Checkr supports companies in adapting to the evolving workforce landscape.
RefleXion Medical Inc. specializes in developing a biologically-guided radiotherapy system aimed at transforming cancer treatment. The company’s innovative technology allows tumors to continuously signal their location during therapy, facilitating the simultaneous treatment of multiple tumors, particularly in cases of metastasis. The RefleXion X1 machine is currently cleared for various forms of radiotherapy, including stereotactic body radiotherapy (SBRT) and intensity-modulated radiotherapy (IMRT). At the core of RefleXion's approach is the integration of positron-emission tomography (PET) imaging, which enables real-time tumor tracking and dose adaptation based on the biological characteristics of the tumors. This advancement in radiotherapy promises to enhance precision in cancer treatment, offering a potential paradigm shift in radiation oncology. RefleXion Medical, incorporated in 2009 and based in Hayward, California, has established strategic collaborations, including partnerships with Telix Pharmaceuticals and HealthMyne.
Shockwave Medical, Inc. is a medical device company that specializes in intravascular lithotripsy technology aimed at treating calcified plaque in patients with various cardiovascular diseases. The company has developed the Lithoplasty™ family of balloon dilatation catheters, which incorporate lithotripsy electrodes to enhance the compliance of rigid vascular and valvular lesions before low-pressure dilation. This approach minimizes injury to healthy tissue and addresses limitations associated with traditional revascularization technologies. Shockwave offers specific catheters for different applications, including M5 catheters for above-the-knee peripheral artery disease, C2 catheters for coronary artery disease, and S4 catheters for below-the-knee peripheral artery disease. The technology is designed to facilitate more effective angioplasty and improve stent delivery, as well as enhance native tissue preparation for trans-catheter aortic valve replacement. Founded in 2009 and headquartered in Santa Clara, California, Shockwave Medical serves interventional cardiologists, vascular surgeons, and interventional radiologists across the United States and internationally.
Wheels Up is a membership-based private aviation company that focuses on reducing the upfront cost to fly privately, providing flexibility, service, and safety. Its mobile app enables members to book flights, manage their accounts, and participate in ride-share opportunities. Its members also have given access to the Wheels Down program. The company was founded in 2013 and headquartered in New York, United States.
Evolve Vacation Rental Network, Inc. operates a marketing and booking platform that offers vacation rental management services for both guests and homeowners. Founded in 2010 and based in Denver, Colorado, the company allows homeowners to effectively market and manage their vacation properties online. Evolve provides a range of services, including professional property listings, marketing, guest communications, and local service provider information. By leveraging a network of vetted local partners, Evolve ensures that essential services such as housekeeping and maintenance are efficiently handled. This approach enables homeowners to achieve higher rental income at reduced costs compared to traditional property management options, while also enhancing the travel experience for guests.
Outset Medical, Inc. is a medical technology company that specializes in developing advanced hemodialysis systems for both acute and chronic patient care. The company's flagship product, the Tablo Hemodialysis System, is a compact and user-friendly dialysis machine designed to provide efficient care in various settings. Tablo integrates essential features such as water purification, on-demand dialysate production, and connectivity capabilities, making it versatile and convenient for healthcare providers. With its wireless data transmission, sensor-based automation, and an intuitive animated touchscreen, Tablo aims to enhance the patient care experience while driving innovation in service models to reduce costs. Founded in 2003 and headquartered in San Jose, California, Outset Medical was previously known as Home Dialysis Plus, Ltd. until its rebranding in 2015.
Home Dialysis Plus, Ltd. provides home hemodialysis solutions to patients and their healthcare providers. Its dialysis system enables hemodialysis treatment in the homes of patients. Home Dialysis Plus, Ltd. was founded in 2003 and is based in Portland, Oregon.
Shockwave Medical, Inc. is a medical device company that specializes in intravascular lithotripsy technology aimed at treating calcified plaque in patients with various cardiovascular diseases. The company has developed the Lithoplasty™ family of balloon dilatation catheters, which incorporate lithotripsy electrodes to enhance the compliance of rigid vascular and valvular lesions before low-pressure dilation. This approach minimizes injury to healthy tissue and addresses limitations associated with traditional revascularization technologies. Shockwave offers specific catheters for different applications, including M5 catheters for above-the-knee peripheral artery disease, C2 catheters for coronary artery disease, and S4 catheters for below-the-knee peripheral artery disease. The technology is designed to facilitate more effective angioplasty and improve stent delivery, as well as enhance native tissue preparation for trans-catheter aortic valve replacement. Founded in 2009 and headquartered in Santa Clara, California, Shockwave Medical serves interventional cardiologists, vascular surgeons, and interventional radiologists across the United States and internationally.
OfferUp provides an online and mobile C2C marketplace app for people to buy and sell electronics, furniture, and cars.
It enables users to post items for sale to friends, followers, people nearby, people of similar interests, moms groups, and craigslist using phones or tablets, browse local items with new postings daily; and message buyers and sellers.
Arean Van Veelen and Nick Huzar founded it in 2011, with its headquarters in Bellevue in Washington.
Magic Leap is a US-based company focused on developing wearable augmented reality technology that enhances user interaction with digital devices. The company is innovating in the augmented reality sector, creating hardware and software designed to provide a unique AR experience that transforms how users access screens and visualize data. Their headset integrates users' natural visual capabilities with mobile computing, producing visual outputs that closely resemble real-world experiences. Utilizing a Dynamic Digitized Lightfield Signal, Magic Leap generates images that are indistinguishable from actual objects, allowing for seamless integration of digital content into the physical environment. The company's platform aims to improve productivity, particularly in enterprise settings, by enabling users to engage with both digital and real-world elements in an immersive manner.
Audentes Therapeutics is a clinical-stage biotechnology company dedicated to developing and commercializing gene therapy products for patients with serious, life-threatening rare diseases caused by single gene defects. The company is advancing several therapies, including AT132, currently in Phase I/II clinical trials for X-linked myotubular myopathy, and AT342, also in Phase I/II studies for Crigler-Najjar syndrome. Additionally, Audentes is exploring AT845 in preclinical studies for Pompe disease and AT307 for the CASQ2 subtype of catecholaminergic polymorphic ventricular tachycardia. The company is also working on vectorized antisense treatments for Duchenne muscular dystrophy and myotonic dystrophy type 1. Collaborations include a partnership with Genethon for XLMTM treatments and an agreement with the University of Pennsylvania for Crigler-Najjar syndrome products. Founded in 2012 and headquartered in San Francisco, California, Audentes Therapeutics operates as a subsidiary of Astellas US Holding, Inc.
OfferUp provides an online and mobile C2C marketplace app for people to buy and sell electronics, furniture, and cars.
It enables users to post items for sale to friends, followers, people nearby, people of similar interests, moms groups, and craigslist using phones or tablets, browse local items with new postings daily; and message buyers and sellers.
Arean Van Veelen and Nick Huzar founded it in 2011, with its headquarters in Bellevue in Washington.
Doximity, founded in 2011 and based in San Francisco, is the largest professional medical network in the United States, with over 70 percent of all U.S. physicians as members. The platform is designed to enhance the productivity and success of medical professionals by facilitating communication among physicians, nurse practitioners, physician assistants, and registered nurses. Doximity enables its users to connect with colleagues and patients, while also providing a space to share insights on current healthcare trends and research. The company was established by the creators of Epocrates and Rock Health, further emphasizing its commitment to improving professional collaboration in the medical field.
Domo, Inc. operates a cloud-based platform in the United States. Its platform digitally connects from the chief executive officer to the frontline employee with the people, data, and systems in an organization, giving them access to real-time data and insights, and allowing them to manage business from smartphones. The company was formerly known as Domo Technologies, Inc. and changed its name to Domo, Inc. in December 2011. Domo, Inc. was founded in 2010 and is headquartered in American Fork, Utah.
Dropbox provides secure file sharing, collaboration, and storage solutions. It aims to unleash the world’s creative energy by designing a more enlightened way of working. 500 million registered users around the world use Dropbox to work the way they want, on any device, wherever they go.
Founded in 2007 by Drew Houston and Arash Ferdowsi, Dropbox is headquartered in San Francisco, California. Moreover, the company has more than 12 offices around the world, with locations in San Francisco, Austin, Dublin, Herzliya, London, New York, Paris, Seattle, Sydney, Hamburg, Washington DC, and Tokyo.
TrialPay, Inc. specializes in cross-platform monetization solutions, allowing customers to pay for one item by trying or purchasing another. Founded in 2006 and headquartered in Mountain View, California, with an additional office in Berlin, Germany, the company offers tools such as Evergreen, which helps developers create custom monetization strategies and connect with customers across various platforms, including the Web, mobile, and social networks. TrialPay's system facilitates free trials and promotional offers for merchants, enabling them to engage users through deals with advertising partners. As of March 2015, TrialPay operates as a subsidiary of Visa Inc.
Peixeurbano is an online platform that enables users to find and book deals on restaurants, air tickets, beauty services, entertainment activities, and trade services according to their localities and preferences. The company was voted "Best International Startup of the Year" by the Crunchies Awards, the United States' top prize for Internet and technology startups. Peixeurbano was established in 2010 and is headquartered in Florianópolis, Brazil.
Zynga Inc. is a prominent developer and operator of social games, offering live services that are accessible on mobile platforms and social networking sites. Founded in 2007 and headquartered in San Francisco, California, Zynga markets popular game franchises, including Slots, Words With Friends, Zynga Poker, and FarmVille. The company's games are available on platforms such as iOS, Android, Facebook, and Snapchat. Zynga generates revenue primarily through mobile game downloads and in-game sales of virtual goods, with a significant portion also coming from advertising services provided to agencies and brokers. The majority of its revenue is derived from online gaming, with its top three games contributing substantially to this segment. Zynga's focus on engaging users through social gaming continues to position it as a leader in the interactive entertainment industry.
Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes novel therapeutics in the areas of thrombosis, and other hematologic disorders and inflammation in Europe and the United States. Its lead product Andexxa, an antidote for the treatment of rivaroxaban and apixaban under the Ondexxya Brand. The company offers Bevyxxa (betrixaban), an oral, once-daily Factor Xa inhibitor for the prevention of venous thromboembolism in adult patients for an acute medical illness. It also develops cerdulatinib, an investigational oral, dual spleen tyrosine kinase, and janus kinases inhibitor for the treatment of hematologic cancers; and Syk inhibitors. Portola Pharmaceuticals, Inc. has collaboration agreements with Bristol-Myers Squibb; Pfizer Inc.; Daiichi Sankyo, Inc.; Bayer Pharma, AG; Takeda, Ora, Inc.; Astellas Pharma Inc.; and Janssen Pharmaceuticals, Inc. The company was founded in 2003 and is headquartered in South San Francisco, California. As of July 1, 2020, Portola Pharmaceuticals, Inc. operates as a subsidiary of Alexion Pharmaceuticals, Inc.
Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes novel therapeutics in the areas of thrombosis, and other hematologic disorders and inflammation in Europe and the United States. Its lead product Andexxa, an antidote for the treatment of rivaroxaban and apixaban under the Ondexxya Brand. The company offers Bevyxxa (betrixaban), an oral, once-daily Factor Xa inhibitor for the prevention of venous thromboembolism in adult patients for an acute medical illness. It also develops cerdulatinib, an investigational oral, dual spleen tyrosine kinase, and janus kinases inhibitor for the treatment of hematologic cancers; and Syk inhibitors. Portola Pharmaceuticals, Inc. has collaboration agreements with Bristol-Myers Squibb; Pfizer Inc.; Daiichi Sankyo, Inc.; Bayer Pharma, AG; Takeda, Ora, Inc.; Astellas Pharma Inc.; and Janssen Pharmaceuticals, Inc. The company was founded in 2003 and is headquartered in South San Francisco, California. As of July 1, 2020, Portola Pharmaceuticals, Inc. operates as a subsidiary of Alexion Pharmaceuticals, Inc.
Terabeam is an American company that designs and manufactures free-space optical transceivers for internet access in downtown areas. Terabeam was founded in 1997 and is located in Kirkland, Washington. As of August 29, 2008, the company operates as subsidiary of Renaissance Electronics & Communications LLC.